KORRO BIO INC (KRRO) Stock Price, Quote, News and Overview
NASDAQ:KRRO - Nasdaq - US5009461089 - Common Stock - Currency: USD
KRRO Quote, Performance and Key Statistics
13.93
-0.87 (-5.88%)
The current stock price of KRRO is 13.93 USD. In the past month the price increased by 8.57%. In the past year, price decreased by -72.69%.
KRRO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.31 | 332.73B | ||
| AMGN | AMGEN INC | 13.29 | 148.31B | ||
| GILD | GILEAD SCIENCES INC | 12.78 | 123.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 111.78B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.66 | 60.56B | ||
| ARGX | ARGENX SE - ADR | 327.86 | 38.04B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.97B | ||
| ONC | BEIGENE LTD-ADR | 5.79 | 25.03B | ||
| BNTX | BIONTECH SE-ADR | N/A | 22.31B | ||
| NTRA | NATERA INC | N/A | 21.77B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.04B | ||
| BIIB | BIOGEN INC | 7.41 | 17.17B |
Related stock screener links
About KRRO
Company Profile
Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company is headquartered in Cambridge, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2019-10-03. The firm discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The firm is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Using its oligonucleotide-based approach, the Company brings its medicines to patients by leveraging its proprietary platform. The Company’s first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD) that has the potential to be disease-modifying and provide a differentiated therapeutic option.
Company Info
KORRO BIO INC
One Kendall Square. Building 600-700, Suite 6-401
Cambridge MASSACHUSETTS US
Employees: 104
Phone: 16174681999
KORRO BIO INC / KRRO FAQ
What is the stock price of KORRO BIO INC today?
The current stock price of KRRO is 13.93 USD. The price decreased by -5.88% in the last trading session.
What is the ticker symbol for KORRO BIO INC stock?
The exchange symbol of KORRO BIO INC is KRRO and it is listed on the Nasdaq exchange.
On which exchange is KRRO stock listed?
KRRO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for KORRO BIO INC stock?
15 analysts have analysed KRRO and the average price target is 124.06 USD. This implies a price increase of 790.58% is expected in the next year compared to the current price of 13.93. Check the KORRO BIO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is KORRO BIO INC worth?
KORRO BIO INC (KRRO) has a market capitalization of 130.80M USD. This makes KRRO a Micro Cap stock.
How many employees does KORRO BIO INC have?
KORRO BIO INC (KRRO) currently has 104 employees.
What are the support and resistance levels for KORRO BIO INC (KRRO) stock?
KORRO BIO INC (KRRO) has a resistance level at 19.6. Check the full technical report for a detailed analysis of KRRO support and resistance levels.
Should I buy KORRO BIO INC (KRRO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KRRO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KRRO, evaluating the profitability, health, valuation and growth aspects
- KORRO BIO INC (KRRO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KORRO BIO INC (KRRO) Sales and EPS estimates to see what analysts future expectations are.
- KORRO BIO INC (KRRO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KORRO BIO INC (KRRO) Insider and Institutional Ownership to learn about the owners and their transactions.
- KORRO BIO INC (KRRO) Stock Chart to make your own analysis
- KORRO BIO INC (KRRO) Latest news and press-releases to stay up to date.
Does KORRO BIO INC (KRRO) stock pay dividends?
KRRO does not pay a dividend.
When does KORRO BIO INC (KRRO) report earnings?
KORRO BIO INC (KRRO) will report earnings on 2025-05-20, after the market close.
What is the Price/Earnings (PE) ratio of KORRO BIO INC (KRRO)?
KORRO BIO INC (KRRO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-9.39).
What is the Short Interest ratio of KORRO BIO INC (KRRO) stock?
The outstanding short interest for KORRO BIO INC (KRRO) is 11.37% of its float. Check the ownership tab for more information on the KRRO short interest.
KRRO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to KRRO. When comparing the yearly performance of all stocks, KRRO is a bad performer in the overall market: 97.46% of all stocks are doing better.
KRRO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KRRO. No worries on liquidiy or solvency for KRRO as it has an excellent financial health rating, but there are worries on the profitability.
KRRO Financial Highlights
Over the last trailing twelve months KRRO reported a non-GAAP Earnings per Share(EPS) of -9.39. The EPS increased by 88.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -36.94% | ||
| ROE | -52.1% | ||
| Debt/Equity | 0 |
KRRO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to KRRO. The Buy consensus is the average rating of analysts ratings from 15 analysts.